Video Upload Options

References

1. Chen PC, Yin J, Yu HW, Yuan T, Fernandez M, Yung CK, Trinh QM, Peltekova VD,Reid JG, Tworog-Dube E, Morgan MB, Muzny DM, Stein L, McPherson JD, Roberts AE,Gibbs RA, Neel BG, Kucherlapati R. Next-generation sequencing identifies rarevariants associated with Noonan syndrome. Proc Natl Acad Sci U S A. 2014 Aug5;111(31):11473-8. doi: 10.1073/pnas.1324128111.
2. Cordeddu V, Yin JC, Gunnarsson C, Virtanen C, Drunat S, Lepri F, De Luca A,Rossi C, Ciolfi A, Pugh TJ, Bruselles A, Priest JR, Pennacchio LA, Lu Z, DaneshA, Quevedo R, Hamid A, Martinelli S, Pantaleoni F, Gnazzo M, Daniele P, LissewskiC, Bocchinfuso G, Stella L, Odent S, Philip N, Faivre L, Vlckova M, Seemanova E, Digilio C, Zenker M, Zampino G, Verloes A, Dallapiccola B, Roberts AE, Cavé H,Gelb BD, Neel BG, Tartaglia M. Activating Mutations Affecting the Dbl HomologyDomain of SOS2 Cause Noonan Syndrome. Hum Mutat. 2015 Nov;36(11):1080-7. doi:10.1002/humu.22834.
3. Flex E, Jaiswal M, Pantaleoni F, Martinelli S, Strullu M, Fansa EK, Caye A, DeLuca A, Lepri F, Dvorsky R, Pannone L, Paolacci S, Zhang SC, Fodale V,Bocchinfuso G, Rossi C, Burkitt-Wright EM, Farrotti A, Stellacci E, Cecchetti S, Ferese R, Bottero L, Castro S, Fenneteau O, Brethon B, Sanchez M, Roberts AE,Yntema HG, Van Der Burgt I, Cianci P, Bondeson ML, Cristina Digilio M, Zampino G,Kerr B, Aoki Y, Loh ML, Palleschi A, Di Schiavi E, Carè A, Selicorni A,Dallapiccola B, Cirstea IC, Stella L, Zenker M, Gelb BD, Cavé H, Ahmadian MR,Tartaglia M. Activating mutations in RRAS underlie a phenotype within theRASopathy spectrum and contribute to leukaemogenesis. Hum Mol Genet. 2014 Aug15;23(16):4315-27. doi: 10.1093/hmg/ddu148.
4. Kouz K, Lissewski C, Spranger S, Mitter D, Riess A, Lopez-Gonzalez V, Lüttgen S, Aydin H, von Deimling F, Evers C, Hahn A, Hempel M, Issa U, Kahlert AK, LiebA, Villavicencio-Lorini P, Ballesta-Martinez MJ, Nampoothiri S, Ovens-Raeder A,Puchmajerová A, Satanovskij R, Seidel H, Unkelbach S, Zabel B, Kutsche K, Zenker M. Genotype and phenotype in patients with Noonan syndrome and a RIT1 mutation.Genet Med. 2016 Dec;18(12):1226-1234. doi: 10.1038/gim.2016.32.
5. Kratz CP, Franke L, Peters H, Kohlschmidt N, Kazmierczak B, Finckh U, Bier A, Eichhorn B, Blank C, Kraus C, Kohlhase J, Pauli S, Wildhardt G, Kutsche K, Auber B, Christmann A, Bachmann N, Mitter D, Cremer FW, Mayer K, Daumer-Haas C,Nevinny-Stickel-Hinzpeter C, Oeffner F, Schlüter G, Gencik M, Überlacker B,Lissewski C, Schanze I, Greene MH, Spix C, Zenker M. Cancer spectrum andfrequency among children with Noonan, Costello, and cardio-facio-cutaneoussyndromes. Br J Cancer. 2015 Apr 14;112(8):1392-7. doi: 10.1038/bjc.2015.75.
6. Milosavljević D, Overwater E, Tamminga S, de Boer K, Elting MW, van Hoorn ME, Rinne T, Houweling AC. Two cases of RIT1 associated Noonan syndrome: Furtherdelineation of the clinical phenotype and review of the literature. Am J MedGenet A. 2016 Jul;170(7):1874-80. doi: 10.1002/ajmg.a.37657.
7. Roberts AE, Allanson JE, Tartaglia M, Gelb BD. Noonan syndrome. Lancet. 2013Jan 26;381(9863):333-42. doi: 10.1016/S0140-6736(12)61023-X.Review.
8. Rohrer T. Noonan syndrome: introduction and basic clinical features. Horm Res.2009 Dec;72 Suppl 2:3-7. doi: 10.1159/000243772.
9. Romano AA, Allanson JE, Dahlgren J, Gelb BD, Hall B, Pierpont ME, Roberts AE, Robinson W, Takemoto CM, Noonan JA. Noonan syndrome: clinical features,diagnosis, and management guidelines. Pediatrics. 2010 Oct;126(4):746-59. doi:10.1542/peds.2009-3207.
10. Schubbert S, Zenker M, Rowe SL, Böll S, Klein C, Bollag G, van der Burgt I,Musante L, Kalscheuer V, Wehner LE, Nguyen H, West B, Zhang KY, Sistermans E,Rauch A, Niemeyer CM, Shannon K, Kratz CP. Germline KRAS mutations cause Noonansyndrome. Nat Genet. 2006 Mar;38(3):331-6.Genet. 2006 May;38(5):598.
11. Sznajer Y, Keren B, Baumann C, Pereira S, Alberti C, Elion J, Cavé H, Verloes A. The spectrum of cardiac anomalies in Noonan syndrome as a result of mutations in the PTPN11 gene. Pediatrics. 2007 Jun;119(6):e1325-31.
12. Tartaglia M, Pennacchio LA, Zhao C, Yadav KK, Fodale V, Sarkozy A, Pandit B,Oishi K, Martinelli S, Schackwitz W, Ustaszewska A, Martin J, Bristow J, Carta C,Lepri F, Neri C, Vasta I, Gibson K, Curry CJ, Siguero JP, Digilio MC, Zampino G, Dallapiccola B, Bar-Sagi D, Gelb BD. Gain-of-function SOS1 mutations cause adistinctive form of Noonan syndrome. Nat Genet. 2007 Jan;39(1):75-9.
13. van der Burgt I. Noonan syndrome. Orphanet J Rare Dis. 2007 Jan 14;2:4.Review.
14. Vissers LE, Bonetti M, Paardekooper Overman J, Nillesen WM, Frints SG, de LigtJ, Zampino G, Justino A, Machado JC, Schepens M, Brunner HG, Veltman JA, SchefferH, Gros P, Costa JL, Tartaglia M, van der Burgt I, Yntema HG, den Hertog J.Heterozygous germline mutations in A2ML1 are associated with a disorderclinically related to Noonan syndrome. Eur J Hum Genet. 2015 Mar;23(3):317-24.doi: 10.1038/ejhg.2014.115.
15. Yamamoto GL, Aguena M, Gos M, Hung C, Pilch J, Fahiminiya S, Abramowicz A,Cristian I, Buscarilli M, Naslavsky MS, Malaquias AC, Zatz M, Bodamer O, MajewskiJ, Jorge AA, Pereira AC, Kim CA, Passos-Bueno MR, Bertola DR. Rare variants inSOS2 and LZTR1 are associated with Noonan syndrome. J Med Genet. 2015Jun;52(6):413-21. doi: 10.1136/jmedgenet-2015-103018.